Revista Peruana de Reumatología: Volumen 2 Nº 2, Año 1996 LIMA-PERÚ


1. Cooper C, Campion G, Melton LJ. Hip fracture in the elderly: A worldwide projection. Osteoporos Int. 2: 285, 1992

2. Favus MJ. Bone Density Reference Data en Primer on the Metabolic Bone Diseases and Disorder of Mineral Metabolism. Lippicott-Raven; 1993; p.426.

3. Heaney RP. Bone mass, nutrition and other life style factors. Am J Med. 1993; 95(5A): 29S.

4. Paganini Hill A, Chao A, Ross RK: Exercise and other factors in the prevention of Hip fractures Epidemiology 1991; 2: 16.

5. Michnovicz JJ, Herschcopf RJ, Naganuma H, et al. Increased 2- Hidroxilation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. N England J Med. 1986; 315: 1, 305.

6. Farley JR, Fitzsimmons R, Taylor AK et al.: Direct effects of ethanol on bone resortion and formation in vitro. Arch biochem Biophys 1985; 238: 305.

7. Assessment of fracture risk and its application to screening for post menopausal osteoporosis. WHO Technical Report Series 843 1994; pp 35.

8. Johnston CC, Melton LJ III, Lindsay R, et al.: clinical indications for bone mass measurements. A report from the scientific advisory board of the National Osteoporosis Foundation. J Bone Mine Res 1989; 4: 1.

9. Reeve J, Meunier PJ, Parsons JA et al.: Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis. A multicentre trial. BMJ 1980; 280: 1340.

10. Ross PD, Wasnich RD, Heilbrun LK et al. Definition of a spine fracture threshold based upon prospective fracture risk. Bone 1987; 8: 271.

11. Keen RW, Spector TD. Secondary prevention of osteoporosis en Rheumatology Highlights 1995, Eular Publishers, 1995; p 79 y sig.

12. Diaz R, Ugarte C. Comunicación Personal de Reporte Anual de Atenciones en Consulta Ambulatoria, Servicio de Reumatología. Hospital Nacional Edgardo Rebagliati Martins, IPSS; 1995.

13. Acevedo E. Comunicación Personal. Servicio de Reumatología del Hospital Nacional Guillermo Almenara Irigoyen, IPSS; 1995.

14. Riggs BL y Melton III LJ. Evidence for two distinct syndromes of involutional osteoporosis. Am J Med. 1983; 75:899.

15. Rico H. Hernández ER, Revilla M et al. Salmó Calcitonin reduces vertebral fracture rate in pos menopausal crush fracture syndrome. Bone Mine 1992; 16:131.

16. Lyritis GP, Tsakalakos S, Magiasis B, et al. Analgesic effect of salmón Calcitonin in Osteoporotic vertebral fractures: Double-blind placebo-controlled Study. Calcif Tissue Int 1991; 49: 369.

17. Pun KK, Chan LWL. Analgesic effect of intranasal salmon calcitonin given by intranasal spray in the treatment of osteoporotic vertebral fractures. Clin Ther 1989; 11: 205.

Regresar al Artículo